Quanta Inc (fka QNTA)

[falon]

I mentioned Scorpion Venom to my Doctor last week and he asked:

Was the company looking for investors?

I said no, they have an IND app in place.

He wanted to know about if there were clinical trials/peer reviews.

I told him there were few.

Scorpion Venom use in the medical arena is not totally new however has been very limited.

Medofile RX is going to take it mainstream.

Certainly people including doctors/scientists are skeptical and rightly so however with clinical trials now being conducted and HARD data available for peer review the skeptics will become fewer and farther between.

This is a ground floor opportunity with a low float and very unique technology.

Follow the Science

Medofile Rx is on track to disrupt the landscape of traditional solutions to medical treatments.

The IND approval of the Covid 19 treatment by the FDA will lay the foundation for Medofile Rx to pursue its other initiatives especially solutions for cancer treatments.

“The FDA-approved therapeutic drug market is the gold standard globally and should we receive IND designation from the FDA, it would catapult our other research across the world,” said Medolife CEO Dr. Arthur Mikaelian. “Submission to the FDA is never easy, but we are generating such positive clinical trial results that we are confident the regulatory body will take notice. They have been reviewing our submission for some time, requesting various other information that we have now submitted. I believe this could be the last request ahead of approval, which would be tremendous not only for our Company, but for patients who are in need of a solution where one does not currently exist. An approval from the FDA would also propel interest from the scientific community on the potential therapeutic benefits of the natural peptides we are studying, including investment and partnership interest.”

It is my belief BIG Pharma is lining up to do business with Medofile Rx as it will be the future for many medical treatments.


What is Medofile Rx?

Quanta Inc., an applied science company, focuses on enhancing energy levels in plant matter (including cannabis) to increase performance within the human body. Its proprietary technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company specializes in potentiating rare, naturally occurring elements to create impactful and sustainable healing solutions that are as powerful and predictable as pharmaceutical drugs. Quanta offers its technology as a platform to product makers through distribution channels as well as consumer products.

What is Medofile Rx“Secret Sauce”?

Polarization Technology (see below)

When asked why large pharmaceutical companies, which spend billions of dollars on cancer research each year, haven't marketed scorpion venom, Mikaelin said, pharmaceutical companies don't study "natural compounds because you can't patent a natural product."

General Science

Escozine™ is a natural compound extracted from the Caribbean Blue Scorpion (Rhopalurus Princeps), which, in its original form, contains low molecular weight peptides, amino acids, proteins and 59 minerals. We have used modern technologies to isolate and filter the essential minerals. The extracted minerals have been polarized by a patented methodology (#US 8,097,284 B2) to increase the potency and binding preferences with abnormal cells. Escozine™ has several paths of influence that affect abnormal cells. The main compound induces Potassium (K+) 3-4 kDa, Sodium (Na+) 6- - 8 kDa and Chloride (Cl+) ionic channel inhibitors.
One of the main components of Escozine™ is a 36 amino acid peptide, which at pH 7 has a high positive charge. It blocks small-conductance chloride channels, and it also binds preferentially to abnormal cells, leaving the normal cells intact.

Patent

The basic principle described in the US Patent # US 8097284 B2 leads to molecular excitement of vibration produced by an electromagnetic field generator, leading to absorption of the quanta of energy for higher potency of the blue scorpion extract, which increases its effectiveness on overall human health at a deep cellular level. Specific frequencies, as well as harmonics, are used to achieve a resonance effect between the generated electromagnetic frequencies and the molecular frequency of the small molecular peptide, specific amino-acids and 59 essential minerals contained in the blue scorpion extract; the electromagnetic vibrational frequency acts as an energy donor and components contained in the scorpion extract act as an energy acceptor. This energy transfer gives more strength, force and potency to the Blue Scorpion extract.

Polarization Technology

A specifically generated monopole electromagnetic vibration creates a resonance effect with Escozine™’s main ingredients at the molecular level; this leads to absorption of energy and shortens the orbital movement of atoms which, in turn, leads to the increase of activity of polarized molecules, and intensifying their potency. Polarization increases the molecular vibration and is excited when the molecule absorbs a quantum of energy, E, corresponding to the vibration’s frequency, ?, according to the relation E = h? (where h is Planck’s constant). A fundamental vibration is excited when one such quantum of energy is absorbed by the molecule in its ground state. This patented technology allows less compounds to be used while increasing the effectiveness of Escozine™’s main ingredients.

Continuation of Patent

Medolife is in the process of applying for a patent continuation, in which these new topics will be covered in detail:

1. Pet product version of patent applies to all different applications of polarized scorpion venom solution for cats and dogs as well as livestock. To find out more, please visit Petlife Pharmaceuticals.

2. The first application of the polarization technology has more general impact on the Blue Scorpion extract, where new multiple frequency generation allows it to target several components in Escozine™ simultaneously. This addition of the patent will be geared towards increasing the potency of specific molecules in the compound to achieve a greater effect on the targeted molecules, amino acids, proteins and peptides. This polarization approach can be applied to any nutraceutical to increase the potency and effectiveness without adding additional ingredients.

3. Escozine GNP-1 is in research and development as an advanced anti-cancer drug. The polarized gold nanoparticles combined with a novel peptide, extracted from the Caribbean Blue Scorpion venom, enhance the bioactive compound and increase the effectiveness of the natural compound up to synthetic drug strength by efficiency. The result is a new category of powerful medications without considerable side effects.

Medolife is presently preparing to apply to the FDA (Food and Drug Administration) for clinical trials in the United States for Escozine GNP-1. The FDA application approach has been validated by a study done in the University of Massachusetts Amherst (UMass Amherst). It suggests that anti-cancer chemotherapies which use gold nanoparticles to deliver chemotherapy drugs deep inside tumor tissues will be more effective if the particles are positively electrically charged; this causes the particles to be more attracted to proliferating cells, according to a team of chemists and chemical engineers at UMass Amherst.

https://medolife.com/about/scientific/